Gastrointestinal Cancer | Topics

Strategies Employing MRD-Guided Treatment for CRC Shows Promise
July 15, 2021

Data in patients with colorectal cancer indicates that the Signatera MRD test may help guide treatment decisions in patients with resectable disease.

Tanios S. Bekaii-Saab, MD, Discusses Key Findings From a Genomic and Immune Profiling Study in Intrahepatic Cholangiocarcinoma
July 12, 2021

At ASCO 2021, Tanios S. Bekaii-Saab, MD, talked about some of his research in patients with IDH1/2–positive cholangiocarcinoma presented at the meeting.

Investigators Continue to Observe Notable Responses With Pembrolizumab/Trastuzumab in HER2+ Gastric/GEJ Cancer
July 09, 2021

Results from the phase 3 KEYNOTE-811 study indicated that pembrolizumab and trastuzumab plus chemotherapy yielded robust, long-lasting responses in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer.